University of Iceland

About: University of Iceland is a education organization based out in Reykjavik, Suðurnes, Iceland. It is known for research contribution in the topics: Population & Genome-wide association study. The organization has 5423 authors who have published 16199 publications receiving 694762 citations. The organization is also known as: Háskóli Íslands.

Epidermal T lymphocytes and HLA-DR expression in psoriasis.

Abstract: Publisher Summary This chapter discusses a study analyzing epidermal T lymphocytes and human leukocyte antigen-DR expression in psoriasis. Twenty patients were studied. None of the patients had been on systemic treatment, including PUVA, for at least 3 months, and all local treatments were stopped at least 2 weeks before biopsy. For analysis, the guttate lesions were divided into early guttate lesions, which were 2 mm or less in diameter and less than 1-week-old, while late guttate lesions were more than l cm in diameter and mostly 3–8 weeks old. Uninvolved skin l cm away was also biopsied. Biopsies were also taken from normal controls. Punch biopsies (2 mm) were frozen immediately in liquid nitrogen and stored at −80°C. DR+ dendritic cells significantly increased in number in early guttate and late guttate lesions compared with normal skin. However, double labeling with OKT6 showed that only approximately 50% of OKT6+ dendritic cells in normal and uninvolved psoriatic skin also expressed DR antigen. In contrast, this proportion increased to 80% in lesions of early and late guttate psoriasis.

Improvements in Implant Dentistry over the Last Decade: Comparison of Survival and Complication Rates in Older and Newer Publications

Abstract: Purpose: The objective of this systematic review was to assess and compare the survival and complication rates of implant-supported prostheses reported in studies published in the year 2000 and before, to those reported in studies published after the year 2000. Materials and Methods: Three electronic searches complemented by manual searching were conducted to identify 139 prospective and retrospective studies on implant-supported prostheses. The included studies were divided in two groups: a group of 31 older studies published in the year 2000 or before, and a group of 108 newer studies published after the year 2000. Survival and complication rates were calculated using Poisson regression models, and multivariable robust Poisson regression was used to formally compare the outcomes of older and newer studies. Results: The 5-year survival rate of implant-supported prostheses was significantly increased in newer studies compared with older studies. The overall survival rate increased from 93.5% to 97.1%. The survival rate for cemented prostheses increased from 95.2% to 97.9%; for screw-retained reconstruction, from 77.6% to 96.8%; for implant-supported single crowns, from 92.6% to 97.2%; and for implant-supported fixed dental prostheses (FDPs), from 93.5% to 96.4%. The incidence of esthetic complications decreased in more recent studies compared with older ones, but the incidence of biologic complications was similar. The results for technical complications were inconsistent. There was a significant reduction in abutment or screw loosening by implant-supported FDPs. On the other hand, the total number of technical complications and the incidence of fracture of the veneering material was significantly increased in the newer studies. To explain the increased rate of complications, minor complications are probably reported in more detail in the newer publications. Conclusions: The results of the present systematic review demonstrated a positive learning curve in implant dentistry, represented in higher survival rates and lower complication rates reported in more recent clinical studies. The incidence of esthetic, biologic, and technical complications, however, is still high. Hence, it is important to identify these complications and their etiology to make implant treatment even more predictable in the future.

The afterglows of swift-era gamma-ray bursts. ii. type i grb versus type ii grb optical afterglows*

Abstract: We use a large sample of GRB afterglow and prompt-emission data (adding further GRB afterglow observations in this work) to compare the optical afterglows (or the lack thereof) of Type I GRBs with those of Type II GRBs. In comparison to the afterglows of Type II GRBs, we find that those of Type I GRBs have a lower average luminosity and show an intrinsic spread of luminosities at least as wide. From late and deep upper limits on the optical transients, we establish limits on the maximum optical luminosity of any associated supernova, confirming older works and adding new results. We use deep upper limits on Type I GRB optical afterglows to constrain the parameter space of possible mini-SN emission associated with a compact-object merger. Using the prompt emission data, we search for correlations between the parameters of the prompt emission and the late optical afterglow luminosities. We find tentative correlations between the bolometric isotropic energy release and the optical afterglow luminosity at a fixed time after trigger (positive), and between the host offset and the luminosity (negative), but no significant correlation between the isotropic energy release and the duration of the GRBs. We also discuss three anomalous GRBs, GRB 060505, GRB 060614, and GRB 060121, in the light of their optical afterglow luminosities. (Abridged)

A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

Abstract: Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.

Screening and prevention of diabetic blindness.

Abstract: Diabetic eye disease remains a major cause of blindness in the world. Laser treatment for proliferative diabetic retinopathy and diabetic macular edema became available more than two decades ago. The outcome of treatment depends on the timing of laser treatment. The laser treatment is optimally delivered when high-risk characteristics have developed in proliferative retinopathy or diabetic macular edema and before this has significantly affected vision. Laser treatment is usually successful if applied during this optimal period whereas the treatment benefit falls sharply if the treatment is applied too late. In order to optimize the timing of laser treatment in diabetic eye disease screening programs have been established. The oldest screening program is 20 years old and several programs have been established during the last decade. In this paper the organisation and methods of screening programs are described including direct and photographic screening. The incidence and prevalence of blindness is much lower in populations where screening for diabetic eye disease has been established compared to diabetic populations without screening. Technical advantages may allow increased efficiency and telescreening. From a public health standpoint screening for diabetic eye disease is one of the most cost effective health procedures available. Diabetic eye disease can be prevented using existing technology and the cost involved is many times less than the cost of diabetic blindness.